Latest Research Reports

Risk of Venous thromboembolism higher in ageing population

Risk of Venous thromboembolism higher in ageing population

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

Burden of Diabetic Foot Ulcers

Burden of Diabetic Foot Ulcers

Importance of reducing the risk for Hepatitis C virus infection

Importance of reducing the risk for Hepatitis C virus infection

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

Long-acting therapies are anticipated to drive human immunodeficiency virus (HIV) market, according to a report by...

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Report: Non-alcoholic steatohepatitis market to witness CAGR of 45%

The non-alcoholic steatohepatitis (NASH) market is projected to grow at a compound annual growth rate (CAGR) of 45% from $618m in 2016 to $25.3bn by 2026, according to a report by...

Report: Non-alcoholic steatohepatitis market to witness CAGR of 45%

Report: HIV market to grow marginally at CAGR of 3% by 2025

The human immunodeficiency virus (HIV) market is projected to increase marginally from $16.3bn in 2015 to $22.5bn by 2025, according to a report by...

Report: HIV market to grow marginally at CAGR of 3% by 2025

Report: New standard-of-care maintenance therapies to drive growth of ovarian cancer market to $5.2bn by 2025

The ovarian cancer market is expected to quadruple, increasing from $1.2bn to $5.2bn in value by 2025, according to a report by...

Report: New standard-of-care maintenance therapies to drive growth of ovarian cancer market to $5.2bn by 2025

The need for action: improving awareness and early diagnosis of SLE

The need for action: improving awareness and early diagnosis of SLE

Urban China stands out from US, major European markets and Japan when comparing invasive breast cancer HER2 status

Urban China stands out from US, major European markets and Japan when comparing invasive breast cancer HER2 status

Geographical variations in spondyloarthropathies prevalence related to HLA-B27 Prevalence

Geographical variations in spondyloarthropathies prevalence related to HLA-B27 Prevalence

Report: Cystic fibrosis market to witness double-digit growth up to 2025

Existing and soon to be launched novel, high-priced, disease-modifying cystic fibrosis transmembrane conductance regulator (CFTR) modulators are anticipated to drive the cystic fibrosis market...

Report: Cystic fibrosis market to witness double-digit growth up to 2025

Report: Novel drugs for unmet needs in rheumatoid arthritis unlikely before 2025

Existing pipeline agents are not expected to address the unmet needs of the rheumatoid arthritis space by 2025, says a report by...

Report: Novel drugs for unmet needs in rheumatoid arthritis unlikely before 2025

Recent failures in Alzheimer’s Research and Development (R&D)

Recent failures in Alzheimer’s Research and Development (R&D)

Report: Immune thrombocytopenia market to witness minimal growth at CAGR of 0.6% by 2025

The immune thrombocytopenia (ITP) market will witness minimal growth from $928m in 2015 to $985m by 2025, says a report by...

Report: Immune thrombocytopenia market to witness minimal growth at CAGR of 0.6% by 2025

Total Prevalent Cases of Dyslipidemia Expected to Grow Globally

Total Prevalent Cases of Dyslipidemia Expected to Grow Globally

Report: Rheumatoid arthritis market projected to reach $28.5bn by 2025

Introduction of interleukin (IL)-6 inhibitors is expected to drive growth in the rheumatoid arthritis space, according to a report by...

Report: Rheumatoid arthritis market projected to reach $28.5bn by 2025

C. difficile pipeline vaccines could offer an alternative to antibiotics

The incidence of Clostridium difficile has increased significantly over the last two decades, due in part to the emergence of new, hyper-virulent strains. In recent years it has surpassed MRSA...

C. difficile pipeline vaccines could offer an alternative to antibiotics

Novavax driving to achieve significant market presence in respiratory complications market

Novavax driving to achieve significant market presence in respiratory complications market